Israel Active

Israel’s MeMed (reported previously) identifies whether an infection is viral or bacterial. MeMed is now working with hospitals in Israel, the Netherlands and elsewhere to identify Covid-19 patients and the potential severity of the infection.

Israel’s Clew Medical (reported previously) has just received US FDA emergency use authorization to remotely identify patients who are likely to experience common coronavirus complications, including respiratory failure and hemodynamic instability.

In a world first, a trial of Ivermectin - an antiparasitic treatment - has been launched at Sheba Medical Center on Covid-19 patients. Ivermectin has been available since 1981 and in the laboratory was recently found to kill the coronavirus within 48 hours.

Israel’s Vectorious Medical Technologies (reported previously) has now patients from Italy, Germany, the UK and Israel, in the trial of its revolutionary in-heart monitor. It is safe and has already detected and prevented pulmonary edema and hospitalization for one elderly UK patient.

Israeli researchers at Bar-Ilan University have identified short amino acid sequences (epitopes), that trigger an immune response to eliminate Covid-19. The discovery could lead to the development of a passive vaccine.

Sheba Medical Center - Israel’s largest hospital - has offered (non-personal) medical data on its 500+ recovered coronavirus patients to innovators, startups, defense companies and the IDF. They have been challenged to build the best artificial intelligence tool for saving lives in future virus outbreaks.

Israel Aerospace Industries (IAI) hopes to win Sheba’s Corona Challenge with its data analysis artificial intelligence system. It gives an 80% accuracy early warning that a Covid-19 patient is likely to suddenly deteriorate in the next hours. IAI uses similar systems to predict likely failure of its satellites.

A new video featuring Israel’s AnapnoGuard (reported previously) which is saving the lives from pneumonia of hundreds of coronavirus patients on ventilators in Israel, the USA and China.

Israeli startup Binah.ai was previously into financial analysis (see ). Now it uses its Artificially Intelligent technology to analyze a video the cheek of a human face to extract vital signs and mental stress measurements. It is used in Montreal hospitals to monitor Covid-19 patients remotely.

Israel’s PixCell (reported previously) has partnered with Interreg Germany-Denmark’s Changing Cancer Care (CCC) initiative. They will assess PixCell’s HemoScreen hematology analyzer for cancer patients to perform blood tests as part of their homecare oncology treatment.